Pharmacy Diversion Awareness Conference
June 4, 2017; Hilton Omaha – Omaha, Nebraska
The Drug Enforcement Administration (DEA) held a Pharmacy Diversion Awareness Conference (PDAC) on June 4, 2017 in Omaha, Nebraska. The conference was developed and designed to address the growing problem of diversion of pharmaceutical controlled substances throughout the United States. In addition to pharmacy robberies and thefts, pharmaceutical controlled substances are often diverted by way of forged prescriptions, doctor shoppers, or illegitimate prescriptions from rogue practitioners. The objective of this conference was to educate pharmacists, pharmacy technicians, and pharmacy loss prevention personnel on ways to address and respond to potential diversion activity.
Over 37 pharmacists, pharmacy technicians, loss prevention personnel, and pharmaceutical students attended. The conference attendees received approximately seven hours of instruction on a variety of topics. The presentations included: Drug Trends, Drugs, Drugs and More Drugs, Nebraska Board of Pharmacy, CMEA Requirements for Retail Distributors, and Diversion Issues.
Select presentations from the Omaha PDAC, as well as a link to the Pharmacy Robbery & Burglary brochure, are below.
Drug Trends – Luis A Carrion, Staff Coordinator, Liaison & Policy Section, Diversion Control Division, DEA
Drugs, Drugs, and More Drugs – William T. Winsley, National Association of Boards of Pharmacy Representative
CMEA Requirements for Retail Distributors – John Purcell, Staff Coordinator, Synthetic Drugs & Chemicals Division, Diversion Control Division, DEA
Medicare Pharmaceutical Diversion – Jason Bell, Operations Officer, Office of Inspector General, U.S. Department of Health and Human Services
Drug Theft and Robberies – Frank Magel, DEA Task Force Officer, Tactical Diversion Squad, St. Louis Office